PARAMETER: heart failure agent to treat hypertension
Recorded at ESC 2015, August 31, 2015 in London, United Kingdom
Prof. Bryan Williams (University College London, United Kingdom)
ESC 2015 The PARAMETER study evaluated LCZ696, the agent that was found to be effective agains heart failure in the PARADIGM-HF, in another population of patients with systolic hypertension.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.